Business Editors/Health/Medical Writers
ELMSFORD, N.Y.--(BUSINESS WIRE)--March 26, 2004
MIM Corporation (NASDAQ:MIMS) (CBOE:OQX) (AMEX:OQX), a pharmaceutical healthcare organization, today announced that the Centers for Medicare and Medicaid Services selected its ScripSolutions
ScripSolutions' Medicare-approved discount card programs are called Freedom and Choice. They provide Medicare beneficiaries with access to discounts averaging approximately 20% on eligible branded and generic prescription medications.
ScripSolutions' discount drug card programs will include the following services for Medicare beneficiaries:
-- Access to virtually all pharmacies in the United States
through the Company's national pharmacy network;
-- 24-hour access to highly qualified pharmacists and customer
service representatives;
-- Drug Utilization Reviews, which identify potential drug
interactions, duplicate drug therapies and many other drug
safety alerts through ScripSolutions' state-of-the-art on-line
claims processing systems linked directly with pharmacies;
-- Online access to ScripSolutions website, which will include
program information and on-line application ability, starting
in May.
MIM already serves as the PBM administrator for several of its clients' discount cash card programs and the Company will partner with its clients to offer the discount card program to their customers.
"We are excited by the opportunity to deliver high quality, low cost drug benefits and comprehensive clinical programs to Medicare beneficiaries," said Mr. Richard H. Friedman, MIM's Chairman and Chief Executive Officer. "Our dedicated customer service and extensive pharmacy network will provide a significant value to participants. MIM has built its reputation of customer satisfaction by providing education and support, utilization monitoring, and ease of access."
MIM Corporation (www.mimcorporation.com) is a pharmaceutical healthcare organization delivering innovative pharmacy benefit and healthcare solutions that provide results beyond expectations. We excel by harnessing our clinical expertise, sophisticated data management, and therapeutic fulfillment capability, and combine it with our dedicated, responsive team of professionals that understands our partners' needs. The result is cost-effective solutions enhancing the quality of patient life.
This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.